133 related articles for article (PubMed ID: 6490649)
1. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system.
Sirotnak FM; Moccio DM; Yang CH
J Biol Chem; 1984 Nov; 259(21):13139-44. PubMed ID: 6490649
[TBL] [Abstract][Full Text] [Related]
2. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
Yang CH; Sirotnak FM; Mines LS
J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
[TBL] [Abstract][Full Text] [Related]
3. Membrane protein changes in an L1210 leukemia cell line with a translocation defect in the methotrexate-tetrahydrofolate cofactor transport carrier.
Schuetz JD; Westin EH; Matherly LH; Pincus R; Swerdlow PS; Goldman ID
J Biol Chem; 1989 Sep; 264(27):16261-7. PubMed ID: 2777791
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.
Roy K; Tolner B; Chiao JH; Sirotnak FM
J Biol Chem; 1998 Jan; 273(5):2526-31. PubMed ID: 9446553
[TBL] [Abstract][Full Text] [Related]
7. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
Henderson GB; Tsuji JM; Kumar HP
Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152
[TBL] [Abstract][Full Text] [Related]
9. Photoaffinity analogues of methotrexate as folate antagonist binding probes. 2. Transport studies, photoaffinity labeling, and identification of the membrane carrier protein for methotrexate from murine L1210 cells.
Price EM; Freisheim JH
Biochemistry; 1987 Jul; 26(15):4757-63. PubMed ID: 3663624
[TBL] [Abstract][Full Text] [Related]
10. Alteration of folate analogue transport inward after induced maturation of HL-60 leukemia cells. Molecular properties of the transporter in an overproducing variant and evidence for down-regulation of its synthesis in maturating cells.
Yang CH; Pain J; Sirotnak FM
J Biol Chem; 1992 Apr; 267(10):6628-34. PubMed ID: 1551871
[TBL] [Abstract][Full Text] [Related]
11. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
Zhao R; Gao F; Goldman ID
Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
14. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo.
Sirotnak FM; Goutas LJ; Mines LS
Cancer Res; 1985 Oct; 45(10):4732-4. PubMed ID: 3875399
[TBL] [Abstract][Full Text] [Related]
15. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
16. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
Yang CH; Dembo M; Sirotnak FM
J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.
Brigle KE; Spinella MJ; Sierra EE; Goldman ID
J Biol Chem; 1995 Sep; 270(39):22974-9. PubMed ID: 7559435
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
Schuetz JD; Matherly LH; Westin EH; Goldman ID
J Biol Chem; 1988 Jul; 263(20):9840-7. PubMed ID: 2838483
[TBL] [Abstract][Full Text] [Related]
19. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
[TBL] [Abstract][Full Text] [Related]
20. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]